N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NuVasive Inc
Research & Development Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Research & Development
-$102.5m
CAGR 3-Years
-11%
CAGR 5-Years
-13%
CAGR 10-Years
-12%
Becton Dickinson and Co
NYSE:BDX
Research & Development
-$1.2B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
-8%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$1.5B
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
-6%
Stryker Corp
NYSE:SYK
Research & Development
-$1.4B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.7B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.1B
CAGR 3-Years
-21%
CAGR 5-Years
-16%
CAGR 10-Years
-20%

See Also

What is NuVasive Inc's Research & Development?
Research & Development
-102.5m USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Research & Development amounts to -102.5m USD.

What is NuVasive Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-12%

Over the last year, the Research & Development growth was -5%. The average annual Research & Development growth rates for NuVasive Inc have been -11% over the past three years , -13% over the past five years , and -12% over the past ten years .

Back to Top